Todd Harris
Co-Founder, CEO, President & DirectorDr. Todd Harris, Ph.D., co-founded Tyra Biosciences, Inc. and serves as President and Chief Executive Officer since November 2018 and Director since August 2018 and had been its Secretary November 2018 and Treasurer since February 2019. Dr. Harris is the Founder of Sienna Biopharmaceuticals, Inc. (Formerly, Sienna Labs, Inc.) since January 29, 2016. Previously as the founder, Chief Executive Officer and director of Sienna (then called Sienna Labs) from April 2013 to January 2016. Dr. Harris was the Head of Corporate Development and a Director at Sienna Biopharmaceuticals, Inc. since January 29, 2016 to July 2018. Dr. Harris served as the Chief Executive Officer of Sienna Biopharmaceuticals, Inc. from July 2010 to January 29, 2016 and served as its President since January 29, 2016. He has worked at the interface of R&D and commercialization of pharmaceutical and medical products for over 10 years. Prior to Sienna Labs, he was a Consultant at McKinsey & Company in the Health Care Practice Division from September 2008 to December 2012. Prior to McKinsey, he was NIH fellow and doctoral student at the Massachusetts Institute of Technology where he developed novel medical technologies for targeting, detecting and treating complex diseases. He had served as a Member of Board of Directors at Primmune Therapeutics, Inc. since founding in October 2017 until June 2024. He received a BS in Electrical Engineering from Brigham Young University, MS in Bioengineering from the University of California, San Diego and a PhD in Medical Engineering and Medical Physics from the Massachusetts Institute of Technology.
Positions
- Company NameTyra Biosciences, Inc.Stock CodeTYRAPositionCo-Founder, CEO, President & DirectorColleagues
